Detection of opioid receptors on murine lymphocytes by indirect immunofluorescence: Mature normal and tumor bearing mice lymphocytes

International Immunopharmacology

Volumn 5, Issue 6, 2005, Pages 1019-1027

  Karaji, Ali Gorgin ^a   Khansari, Nematollah ^a   Ansary, Bita ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G ANTIBODY; NALTREXONE; OPIATE RECEPTOR; PHYCOERYTHRIN; STREPTAVIDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL LABELING; CELL MATURATION; CELL SPECIFICITY; CONJUGATION; CONTROLLED STUDY; FIBROSARCOMA; FLOW CYTOMETRY; FLUORESCENCE; GENE AMPLIFICATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INJECTION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPLEEN CELL; THYMOCYTE;

EID: 17044364983     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.01.012     Document Type: Article

References (47)

1. F.H. Hucklebridge, B.N. Hudspith, P.M. Lydyard, and J. Brostoff Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues Immunopharmacology 19 2 1990 (Mar-Apr) 87 91
2. N.A. Shahabi, and B.M. Sharp Delta opioid agonists inhibit proliferation of highly purified murine CD4+ and CD8+ T-cells Adv Exp Med Biol 373 1995 29 36
3. D.D. Taub, T.K. Eisenstein, E.B. Geller, M.W. Adler, and T.J. Rogers Immunomodulatory activity of mu- and kappa-selective opioid agonists Proc Natl Acad Sci U S A 88 2 1991 (Jan 15) 360 364
4. J.L. Perez-Castrillon, J.L. Perez-Arellano, J.D. Garcia-Palomo, A. Jimenez-Lopez, and S. De Castro Opioids depress in vitro human monocyte chemotaxis Immunopharmacology 23 1 1992 (Jan-Feb) 57 61
5. A.M. Casellas, H. Guardiola, and F.L. Renaud Inhibition by opioids of phagocytosis in peritoneal macrophages Neuropeptides 18 1 1991 (Jan) 35 40
6. J. Prieto, M.L. Subira, A. Castilla, and M. Serrano Naloxone-reversible monocyte dysfunction in patients with chronic fatigue syndrome Scand J Immunol 30 1 1989 (Jul) 13 20
7. R.N. Mandler, W.E. Biddison, R. Mandler, and S.A. Serrate Beta-endorphin augments the cytolytic activity and interferon production of natural killer cells J Immunol 136 3 1986 (Feb 1) 934 939
8. V.K. Ghanta, C.F. Rogers, C.M. Hsueh, N.S. Hiramoto, S.J. Soong, and R.N. Hiramoto In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: their possible role in the conditioned response Int J Neurosci 61 1-2 1991 (Nov) 135 143
9. A. Stephanou, P. Fitzharris, R.A. Knight, and S.L. Lightman Characteristics and kinetics of proopiomelanocortin mRNA expression by human leucocytes Brain Behav Immun 5 4 1991 (Dec) 319 327
10. S.J. Lolait, J.A. Clements, A.J. Markwick, C. Cheng, M. McNally, and A.I. Smith Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages J Clin Invest 77 6 1986 (Jun) 1776 1779
11. J. Martin, M.B. Prystowsky, and R.H. Angeletti Preproenkephalin mRNA in T-cells, macrophages, and mast cells J Neurosci Res 18 1 1987 82 87
12. L.F. Chuang, T.K. Chuang, K.F. Killam Jr, A.J. Chuang, H.F. Kung, and L. Yu Delta opioid receptor gene expression in lymphocytes Biochem Biophys Res Commun 202 3 1994 (Aug 15) 1291 1299
13. C. Gaveriaux, J. Peluso, F. Simonin, J. Laforet, and B. Kieffer Identification of kappa- and delta-opioid receptor transcripts in immune cells FEBS Lett 369 2-3 1995 (Aug 7) 272 276
14. P. Lissoni, S. Barni, F. Paolorossi, S. Crispino, F. Rovelli, and L. Ferri Evidence for altered opioid activity in patients with cancer Br J Cancer 56 6 1987 (Dec) 834 837
15. J.P. Smith, R.L. Conter, T.M. Demers, P.J. McLaughlin, and I.S. Zagon Elevated levels of opioid growth factor in the plasma of patients with pancreatic cancer Pancreas 21 2 2000 (Aug) 158 164
16. T. Gustin, T. Bachelot, J.M. Verna, L.F. Molin, J.F. Brunet, and F.R. Berger Immunodetection of endogenous opioid peptides in human brain tumors and associated cyst fluids Cancer Res 53 19 1993 (Oct 1) 4715 4719
17. N. Gunji, M. Nagashima, G. Asano, and S. Yoshino Expression of kappa-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis Rheumatol Int 19 3 2000 95 100
18. L. Valle, O. Pol, and M.M. Puig Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice J Pharmacol Exp Ther 296 2 2001 (Feb) 378 387
19. D.M. Lawrence, W. el-Hamouly, S. Archer, J.F. Leary, and J.M. Bidlack Identification of kappa opioid receptors in the immune system by indirect immunofluorescence Proc Natl Acad Sci U S A 92 4 1995 (Feb 14) 1062 1066
20. T.A. Ignatowski, and J.M. Bidlack Detection of kappa opioid receptors on mouse thymocyte phenotypic subpopulations as assessed by flow cytometry J Pharmacol Exp Ther 284 1 1998 (Jan) 298 306
21. M. Sedqi, S. Roy, S. Ramakrishnan, R. Elde, and H.H. Loh Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages Biochem Biophys Res Commun 209 2 1995 (Apr 17) 563 574
22. A.E. Takemori, and P.S. Portoghese Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists Eur J Pharmacol 104 1-2 1984 (Sep 3) 101 104
23. V.M. Kolb, A. Koman, and L. Terenius Fluorescent probes for opioid receptors Life Sci 33 Suppl. 1 1983 423 426
24. M.E. Lang, J.S. Davison, S.L. Bates, and J.B. Meddings Opioid receptors on guinea-pig intestinal crypt epithelial cells J Physiol 497 Pt 1 1996 (Nov 15) 161 174
25. B.M. Sharp Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity Adv Exp Med Biol 521 2003 98 105 [Review]
26. T.A. Ignatowski, and J.M. Bidlackk Differential kappa-opioid receptor expression on mouse lymphocytes at varying stages of maturation and on mouse macrophages after selective elicitation J Pharmacol Exp Ther 290 2 1999 (Aug) 863 870
27. D.J. Carr, B.R. DeCosta, C.H. Kim, A.E. Jacobson, V. Guarcello, and K.C. Rice Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes J Endocrinol 122 1 1989 (Jul) 161 168
28. G. Patrini, P. Massi, G. Ricevuti, A. Mazzone, G. Fossati, and I. Mazzucchelli Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone J Pharmacol Exp Ther 279 1 1996 (Oct) 172 176
29. J.M. Bidlack Detection and function of opioid receptors on cells from the immune system Clin Diagn Lab Immunol 7 5 2000 (Sep) 719 723 [Review]
30. A.D. Corbett, S.J. Paterson, and H.W. Kosterlitz A. Herz Selectivity of ligands for opioid receptors Handbook of pharmacology: opioids I vol. 104 1993 Springer-Verlag New York 645 679
31. D.M. Lawrence, I. Hutchinson, A. Seyed-Mozaffari, S. Archer, and J.M. Bidlack Fluorescent staining of kappa opioid receptors using naltrexamine derivatives and phycoerythrin J Immunol Methods 201 2 1997 (Feb 28) 173 181
32. A. Pasi, U. Amsler, and F.S. Messiha Beta-endorphin-like immunoreactivity: assessment of blood levels in patients with tumors of different origin J Med 22 6 1991 327 337
33. P. Chu, S. Murray, D. Lissin, and M. von Zastrow Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist J Biol Chem 272 43 1997 (Oct 24) 27124 27130
34. M.R. Ruff, S.M. Wahl, S. Mergenhagen, and C.B. Pert Opiate receptor-mediated chemotaxis of human monocytes Neuropeptides 5 4-6 1985 (Feb) 363 366
35. B.M. Sharp, W.F. Keane, H.J. Suh, G. Gekker, D. Tsukayama, and P.K. Peterson Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages Endocrinology 117 2 1985 (Aug) 793
36. J. Lin, Y. Shen, Y. Gao, and L. Li Beta-Endorphin enhances IL-2 and IFN-gamma gene expression in human blood mononuclear cells Zhongguo Yixue Kexueyuan Bagao 19 5 1997 (Oct) 353 356 [Chinese]
37. L.M. Hemmick, and J.M. Bidlack Beta-endorphin stimulates rat T lymphocyte proliferation J Neuroimmunol 29 1-3 1990 (Sep-Oct) 239 248
38. H.N. Bhargava, P.T. Thomas, S. Thorat, and R.V. House Effects of morphine tolerance and abstinence on cellular immune function Brain Res 642 1-2 1994 (Apr 11) 1 10
39. G.W. Carpenter, and D.J. Carr Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice Immunopharmacology 29 2 1995 (Mar) 129 140
40. M. Rojavin, I. Szabo, J.L. Bussiere, T.J. Rogers, M.W. Adler, and T.K. Eisenstein Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages Life Sci 53 12 1993 997 1006
41. M.P. Yeager, T.A. Colacchio, C.T. Yu, L. Hildebrandt, A.L. Howell, and J. Weiss Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers Anesthesiology 83 3 1995 (Sep) 500 508
42. I.S. Zagon, J.P. Smith, and P.J. McLaughlin Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor Int J Oncol 14 3 1999 (Mar) 577 584
43. Y. Kikuchi, T. Kita, and I. Nagata Effects of opioid peptides on the cellular immunity in spleen cells from intact nude mice or nude mice bearing human ovarian carcinoma Cancer Immunol Immunother 30 6 1990 374 376
44. P.J. McLaughlin, R.J. Levin, and I.S. Zagon Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice Cancer Lett 199 2 2003 (Sep 25) 209 217
45. R.E. Faith, and A.J. Murgo Inhibition of pulmonary metastases and enhancement of natural killer cell activity by methionine-enkephalin Brain Behav Immun 2 2 1988 (Jun) 114
46. M. Ishikawa, K. Tanno, A. Kamo, Y. Takayanagi, and K. Sasaki Enhancement of tumor growth by morphine and its possible mechanism in mice Biol Pharm Bull 16 8 1993 (Aug) 762 766
47. G.G. Page, S. Ben-Eliyahu, R. Yirmiya, and J.C. Liebeskind Morphine attenuates surgery-induced enhancement of metastatic colonization in rats Pain 54 1 1993 (Jul) 21 28